BROOKE LEVITAN: Open Payments
NPI 1760168975 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 47 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $1,088 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $366 |
| Corcept Therapeutics | 1 | $113 |
| PFIZER INC. | 4 | $77 |
| ABBVIE INC. | 3 | $75 |
| Amgen Inc. | 4 | $71 |
| Lilly USA, LLC | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
| Astellas Pharma US Inc | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Boston Scientific Corporation | 1 | $19 |
Products named: Wegovy, Korlym, Rybelsus, Ozempic, OTEZLA, VRAYLAR, PREVNAR 20, ELIQUIS.
Industry payments across FL — which companies pay providers there.
